Answers are grounded in this paper and cite their sources.
Acute otitis media is the most common condition for which children are brought to medical care and for which antibiotics are prescribed.1Streptococcus pneumoniae is the organism most frequently isolated from middle ear exudate worldwide and causes about 40% of episodes of otitis media, followed by nontypable Haemophilus influenzae and Moraxella catarrhalis.1 In the past pneumococci were exquisitely susceptible to penicillin, but in recent years, strains of S. pneumoniae with decreased susceptibility to penicillin and other beta-lactam drugs have emerged in many countries including Israel.2-4 Middle ear infections caused by antibiotic-resistant pneumococci have shown increased treatment failure rates, posing a difficult therapeutic challenge and a serious public health concern.5, 6 The prevalence of penicillin-resistant strains varies widely among geographic regions and over time, making it necessary to determine and monitor the magnitude of the problem in each location. Because diagnostic tympanocentesis is infrequently performed in children with acute otitis media, information regarding the prevalence of antimicrobial drug resistance among pneumococcal isolates from middle ear fluid is limited. In our center middle ear aspiration has been regularly performed at the Emergency Department since 1992, enabling us to examine the prevalence of antimicrobial drug resistance in a large number of pneumococcal isolates from children with acute otitis media living in southern Israel. Materials and methods. The Clinical Microbiology Laboratory of the Soroka Medical Center is the only facility providing diagnostic bacteriology services to the Negev region of southern Israel, including community and hospital outpatient clinics, inpatient wards and emergency rooms. Middle ear fluid from pediatric patients with acute otitis media presenting to the Emergency Department of the Soroka Medical Center was collected by tympanocentesis or from recent (<5 days) spontaneous eardrum perforation on cotton swabs. Swabs were sent to the Clinical Microbiology Laboratory of the Soroka Medical Center on modified Stewart medium (Medical Wire & Equipment, UK) and arrived within 12 h. Swabs were plated on trypticase agar media containing 5% sheep blood and incubated aerobically at 35°C for 48 h. Presumptive identification of S. pneumoniae was based on presence of alpha-hemolysis and inhibition by optochin and confirmed by a positive slide agglutination test (Phadebact®, Pharmacia Diagnostics, Uppsala, Sweden). Overall between 1500 and 2000 middle ear fluid cultures were processed every year at the laboratory, and the isolation rate of pneumococci during the study period was 40%. Single isolates of each patient were kept frozen at −70°C and tested for susceptibility in batches. All 51 viable pneumococci isolated in 1992, the first 100 organisms isolated in 1993 and 1994 and 109 isolated in 1995 were thawed, subcultured and tested for susceptibility to six clinically relevant antimicrobial drugs. Minimal inhibitory concentration of penicillin, ampicillin, cefuroxime, cefaclor, ceftriaxone and trimmethoprim-sulfamethoxazole (TMP-SMX) was determined by the E-test (PDM Epsilometer®; AB Biodisk, Solna, Sweden) following the manufacturer's recommendations.7 MIC values falling between two marks on the E-test strip were rounded up to the next higher 2-fold dilution as recommended in the packet insert. Interpretation of results was performed according to the National Committee for Clinical Laboratory Standards recommendations.8 Isolates with an MIC value of ≥0.125 ≤1.0 μg/ml were considered intermediate to penicillin, whereas those with MIC values >1.0 μg/ml were defined as resistant. Breakpoints were: for cefuroxime and ceftriaxone, susceptible ≤0.5 μg/ml and resistant ≥2 μg/ml; for TMP-SMX, susceptible ≤10 μg/ml (equivalent to TMP ≤0.5 μg/ml and sulfamethoxazole ≤9.5 μg/ml) and resistant ≥80 μg/ml (equivalent to TMP ≥4.0 μg/ml and SMX ≥76.0 μg/ml). MIC results falling between susceptible and resistant breakpoints were considered to represent intermediate susceptibility. According to the newest National Committee for Clinical Laboratory Standards recommendations, pneumococci susceptible to penicillin can be considered also susceptible to ampicillin and cefaclor. Testing of these two agents against penicillin-resistant isolates is not recommended and reliable interpretative criteria for these antimicrobials are not currently available.8 MIC50 was defined as the minimal concentration of a given antimicrobial drug that inhibited growth of 50% of pneumococcal isolates, and MIC90 was defined as the minimal concentration that inhibited growth of 90% of the isolates. The statistical significance of the differences between proportions was determined by the chi square test. Significance of differences in the prevalence of resistance observed during the study period was calculated using the chi square test for linear trend in proportions. Results. Overall 136 of 360 (38%) pneumococcal isolates exhibited decreased penicillin susceptibility, of which 113 (31%) were intermediate and 23 (6%) were resistant. Prevalence of intermediate susceptibility, resistance and total percentage of isolates with decreased susceptibility (combined intermediate and resistant categories) were, respectively: cefuroxime, 14, 9 and 23%; ceftriaxone, 1, 0.3 and 2%; TMP-SMX, 23, 12 and 35%. In general terms the prevalence of antimicrobial drug resistance gradually increased from 1992 to 1994 and slightly decreased in 1995 to the 1993 level. The increment in the resistance rate observed during the entire study period remained significant for cefuroxime only. Decreased susceptibility to penicillin was significantly associated with reduced susceptibility to TMP-SMX. Eighty-four of 136 (62%) penicillin-intermediate and -resistant pneumococci but only 41 of 224 (18%) penicillin-susceptible organisms were also resistant to TMP-SMX (P < 0.001). The MIC50 and MIC90 of the different antimicrobial drugs tested are shown in Table 1. Clear increases in the MIC50 of cefaclor and cefuroxime and in the MIC90 of ampicillin, cefaclor and cefuroxime were detected during the study period.TABLE 1: MIC50 and MIC90 of six antimicrobial agents tested against 360 Streptococcus pneumoniae isolates from middle ear fluid, 1992 to 1995 Discussion. The results of this study show that decreased antimicrobial susceptibility is widespread among middle ear fluid pneumococci isolated from our pediatric population. The prevalence of decreased penicillin susceptibility (38%) found in southern Israel is one of the highest worldwide, although full resistance (MIC ≥2 μg/ml) appears to be relatively uncommon.2-4 As expected, isolates with decreased susceptibility to penicillin also showed an increased MIC to other members of the beta-lactam class of antimicrobial agents and particularly to ampicillin, cefuroxime and cefaclor. Recent clinical data on the response to therapy of otitis media caused by pneumococci with reduced susceptibility to penicillin have shown that higher failure rates of amoxicillin or cephalosporins occur with pneumococcal isolates exhibiting an MIC of penicillin >0.38 μg/ml.5, 6 This study also confirms the association of diminished susceptibility to penicillin and unrelated antimicrobial agents such as TMP-SMX, which is considered a first line alternative to amoxicillin for treatment of pediatric middle ear infections.1 This association, which is not explained by a common mechanism of resistance, probably results from conservation of a transposon containing resistance genes and maintained by selective pressure exerted on the pneumococci by antimicrobial drugs.2, 9 Children with recurrent episodes of acute otitis media are given a plethora of antimicrobial agents, and under these circumstances multiply resistant pneumococci have a clear biologic advantage over susceptible strains because they are able to survive the hostile environment and disseminate. It may be argued that the population of organisms tested in the present study is skewed because severe cases or treatment failures are overrepresented and therefore that the high prevalence of antimicrobial resistance observed is somewhat exaggerated. A similar bias exists in most other studies because tympanocentesis is not routinely performed for diagnostic bacteriologic purposes of patients with uncomplicated otitis media.1 On the other hand studies conducted in our pediatric population have consistently found a 31 to 40% prevalence of decreased penicillin susceptibility among pneumococcal isolates from nasopharyngeal carriers and children with bacteremia or meningitis.4, 10 The alarming findings of our study indicate that the empiric choice of the appropriate agent for treatment of pediatric otitis media in the region is becoming more difficult because it can no longer be assumed that the causative organisms are susceptible to the antimicrobials in current use. Because of the geographic variability and emergence of antimicrobial resistance among pneumococci, diagnostic tympanocentesis should be performed more often. Aviv Goldbart, M.D. Pablo Yagupsky, M.D. Nufar Markus, B.A. Drora Fraser, Ph.D. Ron Dagan, M.D.
No takes yet. Share an insight, caveat, or question.
Goldbart et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: